Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using mRNA expression profiling to determine anticancer drug efficacy.

Gerrit Los1, Fei Yang, Goli Samimi

  • 1UCSD Cancer Center, University of California at San Diego, La Jolla, California 92037-0058, USA. glos@ucsd.edu

Cytometry
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapamycin alleviates inflammation and muscle weakness, while altering the Treg/Th17 balance in a rat model of myasthenia gravis.

Bioscience reports·2017
Same author

Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer.

International journal of biological sciences·2017
Same author

Cross-resistance to purified Bt proteins, Bt corn and Bt cotton in a Cry2Ab2-corn resistant strain of Spodoptera frugiperda.

Pest management science·2017
Same author

Abnormal asymmetry in benign epilepsy with unilateral and bilateral centrotemporal spikes: A combined fMRI and DTI study.

Epilepsy research·2017
Same author

Lkb1 maintains T<sub>reg</sub> cell lineage identity.

Nature communications·2017
Same author

Corrigendum: EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance.

Nature communications·2017
Same journal

Measurement of the distribution of red blood cell deformability using an automated rheoscope.

Cytometry·2002
Same journal

Flow cytometric-based isolation of nucleated erythroid cells during maturation: an approach to cell surface antigen studies.

Cytometry·2002
Same journal

Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.

Cytometry·2002
Same journal

Determination of bronchoalveolar lavage leukocyte populations by flow cytometry in patients investigated for respiratory disease.

Cytometry·2002
Same journal

Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.

Cytometry·2002
Same journal

Separation of live cells in different phases of the cell cycle for gene expression analysis.

Cytometry·2002
See all related articles

Pharmacogenomics research identifies inherited differences in drug response to personalize cancer treatment. Dynamic expression profiling of cell signaling pathways shows promise for predicting drug efficacy.

Area of Science:

  • Pharmacogenomics
  • Cancer Therapeutics
  • Molecular Biology

Background:

  • Personalized medicine aims to optimize drug selection for individual patients, particularly in cancer treatment.
  • Tumor sensitivity to therapies like chemotherapy and radiation is often poorly understood.
  • Pharmacogenomics investigates genetic influences on drug disposition and effects to guide therapy.

Purpose of the Study:

  • To present two expression profiling approaches for identifying patient responsiveness to cancer treatments.
  • To evaluate the potential of these methods in predicting drug efficacy.

Main Methods:

  • Two expression profiling strategies were employed to assess treatment responsiveness.
  • Approach 1 focused on identifying drug resistance.

Related Experiment Videos

  • Approach 2 analyzed signaling pathways involved in cell death, utilizing dynamic expression profiling.

    • Main Results:

    • Both approaches generated expression profiles.
    • Dynamic expression profiling of damaged cells provided a more detailed view of pharmacogenomic changes.
    • This dynamic profiling demonstrated potential as a superior predictor of drug efficacy.

    Conclusions:

    • Expression profiling is a valuable tool for understanding treatment response in cancer.
    • Dynamic expression profiling of cell signaling pathways offers a promising avenue for predicting pharmacogenomic outcomes.
    • This approach could significantly enhance the selection of optimal drug therapies for cancer patients.